NEW YORK (GenomeWeb) – Three co-founders of 10X Genomics have prevailed in an arbitration dispute brought against them by Bio-Rad Laboratories, 10X Genomics said today.
According to 10X, Bio-Rad brought a claim before the American Arbitration Association in September of 2014, alleging that the three company founders — Serge Saxonov, Benjamin Hindson, and Kevin Ness — had breached certain contractual non-compete, non-solicitation, and confidentiality obligations they allegedly owed to Bio-Rad after it acquired Quantalife in 2011, where all three worked at the time.